These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22264843)

  • 21. High-sensitivity C-reactive protein is associated with the risk of coronary heart disease as estimated by the Framingham Risk Score in middle-aged Japanese men.
    Otsuka T; Kawada T; Katsumata M; Ibuki C; Kusama Y
    Int J Cardiol; 2008 Sep; 129(2):245-50. PubMed ID: 17997174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of cardiovascular risk in primary care patients in France.
    Bruckert E; Bonnelye G; Thomas-Delecourt F; André L; Delaage PH
    Arch Cardiovasc Dis; 2011; 104(6-7):381-7. PubMed ID: 21798470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of cardiovascular risk factors and concentration of C-reactive protein in Type D personality persons without cardiovascular disease.
    Einvik G; Dammen T; Hrubos-Strøm H; Namtvedt SK; Randby A; Kristiansen HA; Somers VK; Nordhus IH; Omland T
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):504-9. PubMed ID: 21450648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of physicians' accuracy in recording with quality of care in cardiovascular medicine.
    Giorda CB; Guida P; Avogaro A; Cortese C; Mureddu GF; Corsini A; Comaschi MA; Manzato E; Volpe M; Zito GB; Medea G; Ventriglia G; Titta G; Riccardi G;
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):722-8. PubMed ID: 19770664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
    Ridker PM
    Am Heart J; 2004 Jul; 148(1 Suppl):S19-26. PubMed ID: 15211329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Tohidi M; Hadaegh F; Harati H; Azizi F
    Int J Cardiol; 2009 Mar; 132(3):369-74. PubMed ID: 18242731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Goal attainment for multiple cardiovascular risk factors in community-based clinical practice (a Canadian experience).
    Farahani P; Levine M
    J Eval Clin Pract; 2009 Feb; 15(1):212-6. PubMed ID: 19239605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
    Silver SA; Huang M; Nash MM; Prasad GV
    Transplantation; 2011 Jul; 92(2):183-9. PubMed ID: 21558986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.
    Sajadieh A; Nielsen OW; Rasmussen V; Ole Hein H; Hansen JF
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1188-94. PubMed ID: 17100670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification.
    Grewal J; Chan S; Frohlich J; Mancini GB
    Clin Invest Med; 2003 Aug; 26(4):158-65. PubMed ID: 12934819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
    Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
    Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
    De Socio GV; Parruti G; Quirino T; Ricci E; Schillaci G; Adriani B; Marconi P; Franzetti M; Martinelli C; Vichi F; Penco G; Sfara C; Madeddu G; Bonfanti P;
    J Infect; 2008 Jul; 57(1):33-40. PubMed ID: 18436307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.